Behbahani Ali 4

4 · Monte Rosa Therapeutics, Inc. · Filed Jul 6, 2026

AI-generated summary of this filing

Updated Jul 6, 2026

Monte Rosa (GLUE) Director Behbahani Ali Reports 1,000,000-Share Distribution

What Happened

Behbahani Ali, a director of Monte Rosa Therapeutics, reported related-party distributions on July 1, 2026. The filing shows: a pro rata distribution by NEA 17 of 1,000,000 shares (reported as a disposition, $0.00 per share), an acquisition of 15,000 shares by NEA Partners 17 (reported at $0.00), and a subsequent distribution by NEA Partners 17 of 15,000 shares (reported as a disposition, $0.00). These transactions were internal distributions among NEA-affiliated entities and involved no cash proceeds.

Key Details

Transaction date(s): July 1, 2026
Reported prices: $0.00 per share for all transactions (pro rata distributions / no consideration)
Notable footnotes:
- NEA 17 made a pro rata distribution of 1,000,000 shares to its GP and LPs (F1).
- The reporting person is manager of NEA 17 GP and disclaims beneficial ownership of securities in which they have no pecuniary interest (F2, F4).
- NEA Partners 17 received 15,000 shares in the NEA 17 distribution (F3) and then distributed 15,000 shares for no consideration (F5).
Shares owned after the transaction: not specified in the filing.
Filing timeliness: Form filed July 6, 2026 for a July 1 transaction. Section 16 filings are generally required within two business days; this filing appears to have been submitted after that window.

Context

These were internal entity distributions (code J) among venture capital/partnership entities affiliated with the reporting person, not open-market sales or purchases by the director personally. Because the reporting person disclaims beneficial ownership of portions where they have no pecuniary interest, these entries reflect institutional reallocation rather than a personal buy/sell decision. Such distributions typically do not signal the director’s personal market view.

Form 4

Period: 2026-07-01

Director

Transactions

Other
Common Stock
[F1][F2]
2026-07-01−1,000,000→ 6,692,298 total(indirect: See Note 2)
Other
Common Stock
[F3][F4]
2026-07-01+15,000→ 15,000 total(indirect: See Note 4)
Other
Common Stock
[F5][F4]
2026-07-01−15,000→ 0 total(indirect: See Note 4)

Footnotes (5)

[F1]New Enterprise Associates 17, L.P. ("NEA 17") made a pro rata distribution of 1,000,000 shares of Common Stock of the Issuer to its general partner and limited partners for no consideration on July 1, 2026.
[F2]The Reporting Person is a manager of NEA 17 GP, LLC ("NEA 17 GP"), which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of NEA 17, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
[F3]NEA Partners 17 received 15,000 shares of Common Stock of the Issuer in the distribution made by NEA 17 on July 1, 2026.
[F4]The Reporting Person is a manager of NEA 17 GP, the sole general partner of NEA Partners 17, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 17 in which the Reporting Person has no pecuniary interest.
[F5]NEA Partners 17 made a distribution of 15,000 shares of Common Stock of the Issuer for no consideration on July 1, 2026.

Signature

/s/ Zachary Bambach, attorney-in-fact|2026-07-06

1 file